Maynard Um
-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Misses Q2 EPS by 3c
-
-
-
-
-
-
-
Atea Pharmaceuticals Inc. (AVIR) Appoints Arthur S. Kirsch to its Board
-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Tops Q2 EPS by 18c
396,792 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

